Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance

Fei Cao, Yulong Li, Furong Ma, Zumei Wu, Zheshen Li, Zhe-Sheng Chen, Xiangdong Cheng, Jiang-Jiang Qin and Jinyun Dong

RSC Med. Chem., 2024, 15, 506
DOI: 10.1039/D3MD00612C

Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies

Manankar Koley, Jianlin Han, Vadim A. Soloshonok, Subhajit Mojumder, Ramin Javahershenas and Ata Makarem

RSC Med. Chem., 2024, 15, 10
DOI: 10.1039/D3MD00511A

Coumarin-1,2,3-Triazole Conjugates as Molecular Scaffolds for the Selective Induction of ROS-Driven Apoptosis in Cancer Cells in the Development of Pyruvate Kinase M2 Inhibitors

Gabriel Ouverney, Amanda de Andrade Borges, Acácio Souza da Silva, Caroline Reis Santiago Paschoal, Paula Alvarez Abreu, Analice Gonçalves Rodrigues da Cruz, Mateus de Freitas Brito, Lucas Silva Abreu, Vitor Francisco Ferreira, Fernando de Carvalho da Silva, Bruno Kaufmann Robbs and Luana da Silva Magalhães Forezi

ACS Omega, 2025, 10, 61899
DOI: 10.1021/acsomega.5c08635

Recent findings on the anticancer potential of coumarin hybrid derivatives

Mohd Akil, Chandra Shekhar Yadav, Atul Krishna

Recent findings on the anticancer potential, 2026, 52
DOI: 10.12692/ijb/28.3.52-79

Cu‐Catalyzed Synthesis of Coumarin‐1,2,3‐Triazole Hybrids connected with Quinoline or Pyridine Framework**

Matina D. Douka, Ioanna M. Sigala, Eleni Nikolakaki, Kyriakos C. Prousis, Dimitra J. Hadjipavlou‐Litina and Konstantinos E. Litinas

ChemistrySelect, 2024, 9
DOI: 10.1002/slct.202401957

The current landscape of coumarin hybrids with antibreast cancer therapeutic applications: An updated review

Ruo Wang, Zilong Chen, Yiheng Huang, Qianru Zhang, Min Chen and Xufeng Huang

Archiv der Pharmazie, 2024, 357
DOI: 10.1002/ardp.202400438

Identification and nanoformulation study of novel 1,2,3-triazole clickamers as potential antivirals against H5N1 and SARS-CoV-2

Hany F. Nour, Ahmed Kandeil, Yaseen A.M.M. Elshaier, Nahla Sameh Tolba, Mohamed Gaballah, Ahmed A. El-Rashedy and Tamer El Malah

Journal of Molecular Structure, 2025, 1339, 142384
DOI: 10.1016/j.molstruc.2025.142384

Hybrid Coumarins in Oncology: Design Strategies and Multi-target Mechanisms Against Tumor Resistance

Yasser Fakri Mustafa

Ind J Clin Biochem, 2025
DOI: 10.1007/s12291-025-01382-5

1,2,3-Triazole-modified sorafenib derivatives induce DNA damage, apoptosis, and PI3K/AKT pathway suppression in hepatocellular carcinoma: Design, synthesis, and evaluation

Longfei Mao, Junfei Wu, Yimian Wang, Mengmeng Huang, Qingqing Zhang, Xixi Hou and Sanqiang Li

Bioorganic Chemistry, 2025, 167, 109210
DOI: 10.1016/j.bioorg.2025.109210

Rational design of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors featuring 1,2,3-triazole derivatives with enhanced anti-inflammatory and analgesic efficacy

Qingying Liu, Xixi Hou, Yueliang Wang, Mingyue Tian, Baoyu He, Jingjing Guo and Jianxue Yang

Front. Pharmacol., 2025, 16
DOI: 10.3389/fphar.2025.1574007

The anti‐breast cancer therapeutic potential of 1,2,3‐triazole‐containing hybrids

Juntao Song, Shuai Zhang, Bo Zhang and Junwei Ma

Archiv der Pharmazie, 2024, 357
DOI: 10.1002/ardp.202300641

The current landscape of 1,2,3‐triazole hybrids with anticancer therapeutic potential: Part I

Shanshan Huang, Zhi Xu and Yafei Zhuang

Archiv der Pharmazie, 2025, 358
DOI: 10.1002/ardp.202500001

Activity Study of Cabotegravir Derivatives Inducing Mitochondrial Apoptosis in HeLa Cells

Yue Song, An Zhan, Yimian Wang, Xiaoting Zhang, Lan Wang and Xixi Hou

Russ J Org Chem, 2025, 61, 2290
DOI: 10.1134/S1070428025601165

In Silico Identification of Potential BACE1 Inhibitors from Ruta graveolens Essential Oil Targeting Alzheimer's Disease

Anandaraj Lakshmanan, Monishsanthosh Ramesh, Tamilarasi Sambu Periyasamy, Nishu Sekar and Hariprasath Lakshmanan

ChemistrySelect, 2026, 11
DOI: 10.1002/slct.202507023

In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer

Sunil Kumar, Iqra Ali, Faheem Abbas, Faiza Shafiq, Ashok Kumar Yadav, Manjunath D. Ghate and Deepak Kumar

Mol Divers, 2024, 28, 4301
DOI: 10.1007/s11030-024-10817-9

New Copper(I) oxide biocatalyst based on functionalized olive stone for the synthesis of 1,4-disubstituted-1,2,3-triazoles under very mild conditions

Arantxa Forte-Castro, Juana M. Pérez, Celia García-Mañas, Gracia García-García, Pedro Urquiza, Tania Romacho and Ignacio Fernández

Sustainable Chemistry and Pharmacy, 2024, 42, 101832
DOI: 10.1016/j.scp.2024.101832

Energy Landscape Mapping–Guided Rational Design of Coumarin‐Based PARP‐1 Inhibitors

Pattem Rambabu, B. Babu, Aryan Jangra, Byran Gowramma, Sivaselvakumar Muthusamy and Vishwottam Kandikere

ChemistrySelect, 2025, 10
DOI: 10.1002/slct.202503552